Skip to content

SENOLOGIE CRELOM

Active
Private limited companyfounded 2025active for 1 yearBoulevard Piercot 18, 4000 Liège, BelgiumKBO/BCE: BE 1018.546.223
Summary

SENOLOGIE CRELOM has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €270,393 and a net result of €267,393. The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Activity
“L'exercice de la médecine par le ou les actionnaires qui la composent” (deed in French)
From the articlesNo NACE code in the KBO yet1 site
Size
€279,085total assets 2025
Equity
€270,393
Profit
€267,393
Turnover not published (micro format)
Financial health
99 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Structure
2025 accounts 35 days early
Why 99raises riskFounded in 2025lowers riskSize: total assets €279,085Liquidity: current ratio 33.73, cash €235,549Equity €270,393 (96.9% of total assets)Show the evidence

Checked score

Score 2025
99 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 89% of its sector peers (no NACE code, micro)
Financial strength
Strong
Solvency 100
equity 96.9% of total assets
Liquidity 100
short-term debt 2.5% · cash 84.4%
Profitability 100
return on assets 95.8%
Bankruptcy probability, 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 02-2026: 2.4% 03-2026: 2.4%● unchanged vs 02-2026 04-2026: 2.5%▲ +0.1 percentage points vs 03-2026 05-2026: 3.0%▲ +0.5 percentage points vs 04-2026 06-2026: 3.1%▲ +0.1 percentage points vs 05-2026 07-2026: 3.3%▲ +0.2 percentage points vs 06-2026 08-2026: 3.6%▲ +0.3 percentage points vs 07-2026highest value 09-2026: 3.5%▼ -0.1 percentage points vs 08-2026 10-2026: 0.1%▼ -3.4 percentage points vs 09-2026lowest value
Credit of up to €25,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 33.73, above the usual 1.5; short-term debt: 2.5% and cash: 84.4% of total assets), and 3.1% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro): better than 81% on solvency, 95% on liquidity and 90% on profitability.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Size: total assets €279,085
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 33.73, cash €235,549
NBB · annual accounts
lowers risk · Equity €270,393 (96.9% of total assets)
NBB · annual accounts
raises risk · Founded in 2025
Companies of this age fail more often than older ones; how much that weighs depends on the rest of its profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 26-06-2026, 35 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
35 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2025.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. IncorporationAppointments: CREVECOEUR André (director) and…

Key points

  • Board2 directors in office 2 View
  • Total assets 2025first financial year filed €279,085 View
  • Active since 2025founded 10-01-2025 1 years View

By topic

Financials

Financial year
2025
Total assets
€279,085
Profit
€267,393
Solvency
96.9%
Go to Financials

Company details

Sites
1
Legal form
Private limited company
Founded
10-01-2025
Year ends
31-12
Peppol
Not found in the Peppol directory
Go to Company details

Articles of association

Provisions read
37
Annual meeting
Fourth Thursday of June at 18:00
Purpose
“L'exercice de la médecine par le ou les actionnaires qui la composent” (deed in French)
Statutory auditor
No statutory auditor
Go to Articles of association

Key facts about SENOLOGIE CRELOM

What is the company number of SENOLOGIE CRELOM?
1018.546.223. In Belgium the VAT number is the company number with BE in front: BE 1018.546.223.
Where is SENOLOGIE CRELOM based?
The registered office is at Boulevard Piercot 18, 4000 Liège.Company details
What is the legal form of SENOLOGIE CRELOM?
Private limited company (BV).
When was SENOLOGIE CRELOM founded?
On 10-01-2025.
Is SENOLOGIE CRELOM still active?
Yes, SENOLOGIE CRELOM is an active enterprise in the KBO register.
What is the turnover of SENOLOGIE CRELOM?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is SENOLOGIE CRELOM profitable?
In financial year 2025, SENOLOGIE CRELOM made a profit of €267,393.
Where can I find the annual accounts of SENOLOGIE CRELOM?
SENOLOGIE CRELOM filed 1 annual account with the National Bank of Belgium, for financial year 2025.

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.